Want to join the conversation?
$MS' compensation expense for 2Q16 fell to $4Bil from $4.4Bil in the previous year quarter, partially driven by lower revenues. Non-compensation expenses declined to $2.4Bil from $2.6Bil a year ago. CEO James Gorman said $MS' results reflect solid performance in an improved but still fragile environment.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?